metformin a glp 1 or Comparing Glucagon‐like peptide‐1 receptor agonists versus in drug‐naive patients: nationwide cohort study - Sørensen - 2024 Clinical Focus on GLP-1 Agonists

I was ashamed of taking (and for needing in the first place) a medication that so many people still consider the easy way out. A 2025 study in the International Journal of Obesity confirmed what we all know: Women who use a GLP-1 often report feeling judged for taking a shortcut to lose weightcheating...and perpetuating thin-culture. Worst of all

Below that shared point, the two diverge completely

Research has explored applications in tendon and ligament injuries, muscle tears, post-surgical healing, and tendon-to-bone reconnection

Michigan, North Carolina and Rhode Island have already or may restrict coverage due to budget limits, while others debate expansion

NICE guideline NG198